Title: Impact of species-dependent differences on screening, design, and development of MAO B inhibitors.
Journal: Journal of medicinal chemistry 20061019
136716-38-6
77152-22-8
337921-77-4
147508-60-9
303145-61-1
147508-54-1
194282-56-9 | 2-amino-6-(hydroxymethyl)-4-(4-methoxyphenyl)-8-oxo-4H,8H-pyrano[3,2-b]pyran-3-carbonitrile | AA00IQ9E | MFCD03787430
151504-48-2 | 4-hydroxy-6-methyl-3-[(1E)-1-[2-(4-phenyl-1,3-thiazol-2-yl)hydrazin-1-ylidene]ethyl]-2H-pyran-2-one | AA00IQC7 | MFCD00141236
15031-03-5 | 2-[(1H-pyrrol-2-yl)methylidene]propanedinitrile | AA00IQES | MFCD00173105
318469-58-8 | ethyl 2-[1-(4-methoxybenzenesulfonyl)-3-oxopiperazin-2-yl]acetate | AA00IQI1 | MFCD00173274
860785-50-8 | 4-[benzyl(ethyl)amino]-1-methyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid | AA00IQKT | MFCD04124525
27393-78-8 | 3-(pyrrolidine-1-carbonyl)-1H-indole | AA00IQNV | MFCD03305785
320418-16-4 | 4-(dimethylamino)-6-phenyl-2-(pyridin-2-yl)pyrimidine-5-carbonitrile | AA00IQQD | MFCD20921592
339031-57-1 | ethyl 6-oxo-1-phenyl-4-(propylsulfanyl)-1,6-dihydropyridazine-3-carboxylate | AA00IQTD | MFCD00243746
439110-67-5 | methyl 2-{[4-(thiophen-2-yl)pyrimidin-2-yl]sulfanyl}acetate | AA00IQW1 | MFCD00973888
339106-68-2 | N2-tert-butyl-5-(4-fluorobenzoyl)-1,3-thiazole-2,4-diamine | AA00IQZ6 | MFCD01443916